UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

International standardization and classification of human papillomavirus types

Virology (New York, N.Y.), 2015-02, Vol.476, p.341-344

2015

Volltextzugriff (PDF)

Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2

Nature communications, 2021-06, Vol.12 (1), p.3695-3695, Article 3695

2021

Volltextzugriff (PDF)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR

British journal of cancer, 2020-12, Vol.123 (12), p.1790-1795

2020

Volltextzugriff (PDF)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study

PLoS medicine, 2018-10, Vol.15 (10), p.e1002666-e1002666

2018

Volltextzugriff (PDF)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations

PLoS medicine, 2023-10, Vol.20 (10), p.e1004304-e1004304

2023

Volltextzugriff (PDF)

Global Proficiency Study of Human Papillomavirus Genotyping

Journal of Clinical Microbiology, 2010-11, Vol.48 (11), p.4147-4155

2010

Volltextzugriff (PDF)

Global Improvement in Genotyping of Human Papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study

Journal of Clinical Microbiology, 2014-02, Vol.52 (2), p.449-459

2014

Volltextzugriff (PDF)

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs

American journal of epidemiology, 2021-04, Vol.190 (4), p.506-514

2021

Volltextzugriff (PDF)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial

PLoS medicine, 2021-08, Vol.18 (8), p.e1003748-e1003748

2021

Volltextzugriff (PDF)

Increasing participation in cervical screening by targeting long‐term nonattenders: Randomized health services study

International journal of cancer, 2019-12, Vol.145 (11), p.3033-3039

2019

Volltextzugriff (PDF)

Antibodies to SARS-CoV-2 and risk of past or future sick leave

Scientific reports, 2021-03, Vol.11 (1), p.5160-5160, Article 5160

2021

Volltextzugriff (PDF)

Sequencing detects human papillomavirus in some apparently HPV-negative invasive cervical cancers

Journal of general virology, 2020-03, Vol.101 (3), p.265-270

2020

Volltextzugriff (PDF)

Beta and gamma human papillomaviruses in anal and genital sites among men: prevalence and determinants

Scientific reports, 2018-05, Vol.8 (1), p.8241-10, Article 8241

2018

Volltextzugriff (PDF)

The HPV16 Genome Is Stable in Women Who Progress to In Situ or Invasive Cervical Cancer: A Prospective Population-Based Study

Cancer research (Chicago, Ill.), 2019-09, Vol.79 (17), p.4532-4538

2019

Volltextzugriff (PDF)

Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil

PloS one, 2022, Vol.17 (1), p.e0262724-e0262724

2022

Volltextzugriff (PDF)

The 2010 Global Proficiency Study of Human Papillomavirus Genotyping in Vaccinology

Journal of Clinical Microbiology, 2012-07, Vol.50 (7), p.2289-2298

2012

Volltextzugriff (PDF)

Unbiased approach for virus detection in skin lesions

PloS one, 2013, Vol.8 (6), p.e65953-e65953

2013

Volltextzugriff (PDF)

Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer

Cancer epidemiology, biomarkers & prevention, 2011-12, Vol.20 (12), p.2541-2550

2011

Volltextzugriff (PDF)

An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report

Preventive medicine reports, 2023-10, Vol.35, p.102368-102368, Article 102368

2023

Volltextzugriff (PDF)

Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study

npj vaccines, 2024-08, Vol.9 (1), p.146-9, Article 146

2024

Volltextzugriff (PDF)

Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study

PloS one, 2016-05, Vol.11 (5), p.e0156215

2016

Volltextzugriff (PDF)

WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58

npj vaccines, 2024-09, Vol.9 (1), p.165-13, Article 165

2024

Volltextzugriff (PDF)

Expressed prostate secretions in the study of human papillomavirus epidemiology in the male

PloS one, 2013-06, Vol.8 (6), p.e66630-e66630

2013

Volltextzugriff (PDF)

Chlamydia trachomatis Strain Types Have Diversified Regionally and Globally with Evidence for Recombination across Geographic Divides

Frontiers in microbiology, 2017-11, Vol.8, p.2195-2195

2017

Volltextzugriff (PDF)

Genotyping of human papillomavirus in triaging of low-grade cervical cytology

American journal of obstetrics and gynecology, 2011, Vol.205 (2), p.145.e1-145.e6

2011

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(112)

Publikationsform

Sprache

Englisch
(136)

Erscheinungsjahr

n.n

Thema

Science & Technology
(103)
Medicin Och Hälsovetenskap
(95)
Life Sciences & Biomedicine
(94)
Humans
(69)
Female
(48)
Human Papillomavirus
(48)
Medical And Health Sciences
(40)
Adult
(31)
Middle Aged
(30)
Cervical Cancer
(28)
Virology
(24)
Health Sciences
(23)
Hälsovetenskap
(23)
Occupational Therapy
(23)
Oncology
(23)
Papillomaviridae - Genetics
(20)
Male
(19)
Papillomavirus Infections - Epidemiology
(18)
Papillomavirus Infections - Virology
(18)
Uterine Cervical Neoplasms - Virology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

International standardization and classification of human papillomavirus types

Multianalyte serology in home-sampled blood enables an unbiased assessment of the immune response against SARS-CoV-2

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study

Impact of cervical screening by human papillomavirus genotype: Population-based estimations

Global Proficiency Study of Human Papillomavirus Genotyping

Global Improvement in Genotyping of Human Papillomavirus DNA: the 2011 HPV LabNet International Proficiency Study

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial

Increasing participation in cervical screening by targeting long‐term nonattenders: Randomized health services study

Antibodies to SARS-CoV-2 and risk of past or future sick leave

Sequencing detects human papillomavirus in some apparently HPV-negative invasive cervical cancers

Beta and gamma human papillomaviruses in anal and genital sites among men: prevalence and determinants

The HPV16 Genome Is Stable in Women Who Progress to In Situ or Invasive Cervical Cancer: A Prospective Population-Based Study

Human Papillomavirus (HPV) seroprevalence, cervical HPV prevalence, genotype distribution and cytological lesions in solid organ transplant recipients and immunocompetent women in Sao Paulo, Brazil

The 2010 Global Proficiency Study of Human Papillomavirus Genotyping in Vaccinology

Unbiased approach for virus detection in skin lesions

Prospective Seroepidemiologic Study of Human Papillomavirus and Other Risk Factors in Cervical Cancer

An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report

Lack of detectable HPV18 antibodies in 14% of quadrivalent vaccinees in a longitudinal cohort study

Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study

WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58

Expressed prostate secretions in the study of human papillomavirus epidemiology in the male

Chlamydia trachomatis Strain Types Have Diversified Regionally and Globally with Evidence for Recombination across Geographic Divides

Genotyping of human papillomavirus in triaging of low-grade cervical cytology

Suchergebnisse filtern